Biocon Q1 Profit Soars 348% to ₹141 Cr, Revenue Up 10%
By ThePip Desk
Biocon Ltd. reports a stellar Q1 FY27 with net profit surging 348.4% to ₹141 crore and revenue climbing 10% to ₹4,336 crore. Explore key financial highlights.
Biocon Ltd. has reported a substantial 348.4% year-on-year surge in its consolidated net profit, reaching Rs 141 crore for the quarter ending June 2026. This marks a significant increase from the Rs 31.4 crore recorded in the same period last year.
The company’s financial performance also saw its revenue from operations grow by 10% year-on-year, exceeding the Rs 4,300 crore mark. Total revenue for the quarter stood at Rs 4,336 crore.
Key Financial Highlights Q1 FY27
- Consolidated Net Profit: Rs 141 crore, up 348.4% YoY.
- Previous Year Net Profit: Rs 31.4 crore.
- Revenue from Operations: Rs 4,336 crore, a 10% YoY increase.
- EBITDA: Rose by 10.6% to Rs 847 crore.
- EBITDA Margin: Maintained at 19.53%.
Earnings Before Interest, Taxes, Depreciation, and Amortisation (EBITDA) demonstrated a robust increase of 10.6%, reaching Rs 847 crore. Despite the significant profit growth, the EBITDA margin remained stable at 19.53% for the June 2026 quarter.
This strong quarterly performance underscores Biocon’s operational efficiency and highlights a period of notable financial expansion. The reported figures indicate a robust start to the fiscal year for the pharmaceutical company.